181 filings
Page 4 of 10
CORRESP
1w8kp2g651egtdimm
5 Jun 23
Correspondence with SEC
12:00am
UPLOAD
xopaexwg u8itpv9k
5 Jun 23
Letter from SEC
12:00am
ARS
a8mqfsv4 ze3l9hh
26 May 23
Annual report to shareholders
4:38pm
DEFA14A
93o h4m5yqe
26 May 23
Additional proxy soliciting materials
4:19pm
8-K/A
xojlsl43pk8laxm
26 May 23
Financial Statements and Exhibits
4:15pm
D
s790ilwgqjztvy63g5n
27 Apr 23
$15.58 mm in options / securities to be acquired, sold $15.58 mm, 1 investor
9:39am
8-K
engkwuz
27 Apr 23
Other Events
9:12am
8-K
a7gmwtkr4 196
27 Apr 23
Regulation FD Disclosure
8:40am
424B3
b8wbi
21 Apr 23
Prospectus supplement
5:16pm
8-K
3apxkleo3 nxkv
21 Apr 23
Investment proceeds expected to fund planned operations of the combined company into mid-2024
5:14pm
8-K
l018 4e5iz
20 Apr 23
Vallon Pharmaceuticals Announces Stockholder Approval of Merger with GRI Bio, Inc. and Reverse Stock Split
7:38pm
8-K
5o9c6iz qu4
12 Apr 23
Vallon Pharmaceuticals Adjourns Special Meeting of Stockholders Until
4:06pm
425
v9bos8
12 Apr 23
Business combination disclosure
4:06pm
8-K
22t2v
7 Apr 23
Other Events
8:24am
425
xg62t5v1igv3j12w9y
7 Apr 23
Business combination disclosure
8:23am
424B3
9j526uk6grej8jj
7 Apr 23
Prospectus supplement
8:22am
DEFA14A
47ihdma2 8i9apas2gi6
5 Apr 23
Additional proxy soliciting materials
8:22am